Showing results (1471-1480 of 2,509) with videos related to
Sort By:
Pageof 251
Journal of Computational Chemistry|September 15, 2010
Connectivity and binding-site recognition: applications relevant to drug designChristopher J R Illingworth, Paul D Scott, Kevin E B Parkes, et al.The Science of the Total Environment|September 26, 2006
Biogeochemical value of managed realignment, Humber estuary, UKJ E Andrews, D Burgess, R R Cave, et al.Frontiers in Nutrition|October 31, 2022
Influence of traditional processing and genotypes on the antioxidant and antihyperglycaemic activities of yellow-fleshed cassavaBabajide Kareem, Emmanuel Anyachukwu Irondi, Emmanuel Oladeji Alamu, et al.Journal of Diabetes Science and Technology|January 7, 2015
The surveillance error gridDavid C Klonoff, Courtney Lias, Robert Vigersky, et al.The British Journal of Surgery|April 1, 1993
Carcinoid tumours of the appendix in children 1957-1986: incidence, treatment and outcomeS E Parkes, K R Muir, M al Sheyyab, et al.Biochemistry|March 5, 1996
Comparison of the structural requirements for bacteriochlorophyll binding in the core light-harvesting complexes of Rhodospirillum rubrum and Rhodospirillum sphaeroides using reconstitution methodology with bacteriochlorophyll analogsC M Davis, P S Parkes-Loach, C K Cook, et al.Clinical Endocrinology|April 1, 1985
Immunoprecipitation of TSH-TSH receptor complexesA B Parkes, Y Kajita, P R Buckland, et al.Health Trends|July 9, 1986
Making a rehabilitation hospital for the elderly workW Rosenberg, J Parkes, A Jenkins, et al.Proceedings of the National Academy of Sciences of the United States of America|June 16, 2025
Deep mechanism design: Learning social and economic policies for human benefitAndrea Tacchetti, Raphael Koster, Jan Balaguer, et al.Clinical Pharmacokinetics|April 22, 2025
Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung CancerStephanie Kong, Mukul Minocha, Po-Wei Chen, et al.Pageof 251